Indivior Q2 2026 Earnings Call: Complete Transcriptbenzinga_article·Aug 17 at 04:19 AMSUPN-2.25%INDV-3.23%
Key deals this week: Bending Spoons, Advanced Micro Devices, Visa, Prologis, and morebusinessinsider·Aug 9 at 09:59 AMATKR+0.06%LNTH-0.24%
Are DSGR, LNTH, ATKR Obtaining Fair Deals for their Shareholders?PR Newswire·Aug 7 at 01:16 PMDSGR+0.17%ATKR+0.06%
Supernus Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Supernus Pharmaceuticals, Inc. - SUPNMorningStar·Aug 7 at 10:38 AMSUPN-2.25%INDV-3.23%
Supernus and Indivior merge to create scaled, CNS-focused entityPharmaceutical Technology·Aug 4 at 05:57 AMSUPN-2.25%INDV-3.23%
Top 3 Health Care Stocks You'll Regret Missing This Quarterbenzinga_article·Aug 4 at 05:04 AMPTCT-4.28%SUPN-2.25%
15:15 ET$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Indivior Pharmaceuticals, Inc. (NASDAQ: INDV)prnewswire·Aug 3 at 02:16 PMINDV-3.23%SUPN-2.25%
15:13 ET$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN)prnewswire·Aug 3 at 02:13 PMSUPN-2.25%INDV-3.23%
Supernus Pharma shares trading higher after the company reported better-than-expected Q2 financial results. The company also announced a merger with Indivior Pharma to create diversified, CNS biopharmaceutical company.benzinga_article·Aug 3 at 12:55 PMSUPN-2.25%INDV-3.23%
Are SUPN, ITGR, ATKR, LNTH Obtaining Fair Deals for their Shareholders?PR Newswire·Aug 3 at 12:41 PMATKR+0.06%ITGR-0.07%
